Grantham, Mayo, Van Otterloo & Co. LLC

Position in SNY — Sanofi

CIK 1352662 Boston, MA

Position in SNY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$9,109,440

+$4,352,074 QoQ

Shares Held

189,071

+92.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Grantham, Mayo, Van Otterloo & Co. LLC holds $3,657,324,895 across 11 Drug Manufacturers - General names. SNY ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	7,278,866	$1,779,246,005
2	MRK	Merck & Co., Inc.	7,013,777	$843,687,235
3	LLY	ELI LILLY & Co	749,815	$689,657,342
4	GSK	GSK plc	3,522,566	$194,410,417
5	PFE	Pfizer Inc	2,285,443	$64,175,239
6	NVS	Novartis AG	275,637	$42,103,551
7	BMY	Bristol Myers Squibb Co	432,391	$26,224,514
8	SNY	Sanofi This page	189,071	$9,109,440

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,109,440	189,071	+92.6%	Shares	Sole	2026-05-14
2025-12-31	$4,757,366	98,171	+15.3%	Shares	Sole	2026-02-17
2025-09-30	$4,019,740	85,164	+99.6%	Shares	Sole	2025-11-13
2025-06-30	$2,061,532	42,673	+19.2%	Shares	Sole	2025-08-13
2025-03-31	$1,985,911	35,808	+90.6%	Shares	Sole	2025-05-14
2024-12-31	$906,193	18,789	+33.3%	Shares	Sole	2025-02-13
2020-12-31	$685,119	14,100	-88.8%	Shares	Sole	2021-02-12
2020-09-30	$6,308,476	125,742	-58.3%	Shares	Sole	2020-11-13
2020-06-30	$15,383,509	301,342	-29.3%	Shares	Sole	2020-08-13
2020-03-31	$18,639,672	426,342	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.